NDLI: INTEGRATED ANALYSIS IDENTIFIES DIFFERENT METABOLIC SIGNATURES WITHIN BOTH TUMOR-INITIATING CELLS AND STEM CELLS IN A MURINE GLIOBLASTOMA MODEL

Content Provider	PubMed Central
Author	Sampetrean, Oltea Hideyuki, Saya
Copyright Year	2014
Abstract	BACKGROUND: The metabolic preference of malignant gliomas for glycolysis as an energy source is a potential diagnostic and therapeutic target. As a result of the cellular heterogeneity of these tumors, however, the relation between glycolytic preference, tumor formation and tumor maintenance has remained unknown. To address this issue, we analyzed the metabolic profiles of isogenic glioma-initiating cells (GICs) and glioma stem cells (GSCs) in a syngeneic mouse model. METHODS: GICs were established by overexpression of H-RasV12-dsRed in Ink4a/Arf–null neural stem cells. Subpopulations of GICs were obtained by single-cell cloning, and clones differing in extracellular acidification potential were used for quantification of intracellular metabolites and related enzymes. Tumors formed after intracranial implantation of the GIC clones in mice were examined for pathological features of glioma and expression of glycolytic enzymes. GSCs were established by sphere culture of dsRed-positive cells from the primary tumors and assessed for metabolic characteristics. RESULTS: Malignant transformation of neural stem cells resulted in a distinct shift in metabolism, with a significant increase in lactic acid production as the most pronounced characteristic of all malignant cells. Interestingly however, both GICs and GSCs could adopt two different metabolic profiles. Some clones displayed high glucose consumption and lactate production, while others consumed more oxygen, produced more ATP and had a higher respiratory capacity. The glycolytic clones exhibited higher levels of key glycolytic enzymes such as hexokinase 2 and pyruvate kinase M2, and the clones relying on oxidative phosphorylation had lower levels of pyruvate dehydrogenase kinase 1. While all GICs had equal tumorigenic ability, the differential expression of the metabolic enzymes persisted in the tumors formed by these clones in vivo, as well as in the GSCs of the respective tumors. CONCLUSIONS: The metabolic characteristics of glioma cells appear early during malignant transformation and persist until the late stages of tumor formation. However, even isogenic clones may be heterogeneous in terms of metabolic features, with both GICs and GSCs being able to satisfy their bioenergetics needs not only through aerobic glycolysis, but also through oxidative phosphorylation. These results suggest that a more detailed understanding of the metabolic profile of glioma is imperative for effective diagnostic and therapeutic targeting. SECONDARY CATEGORY: n/a.
Related Links	http://dx.doi.org/10.1093/neuonc/nou206.68
Starting Page	19
File Format	PDF
ISSN	15228517
e-ISSN	15235866
Journal	Neuro-Oncology
Issue Number	Suppl 3
Volume Number	16
Language	English
Publisher	Oxford University Press
Publisher Date	2014-07-01
Access Restriction	Open
Rights Holder	Oxford University Press
Subject Keyword	Cancer Research Oncology Clinical Neurology Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Cancer Research Neurology (clinical) Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model

P53THE METABOLIC AUTOPHAGY PATHWAY REGULATES THE RESPONSE TO TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME-INITIATING STEM CELLS

SC-15ISOLATING GLIOBLASTOMA TUMOR INITIATING PROGENITOR CELLS FROM THE SUBVENTRICULAR ZONE USING A NOVEL MINIMALLY INVASIVE APPROACH

Targeting Glioma Stem Cells

COMBINED DRUG SCREENING AND PHOSPHOPROTEOMICS IDENTIFIES CANDIDATE BRAIN TUMOR THERAPEUTICS AND NOVEL TARGETS IN PRIMARY HUMAN BRAIN TUMOR-INITIATING CELLS

Na+/K+-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

CB-15NKCC1 REGULATES MIGRATION CAPACITY OF GLIOBLASTOMA TUMOR INITIATING CELLS BY MODULATING ACTIN CYTOSKELETON THROUGH SMALL RHO GTPASES

INTEGRATED ANALYSIS IDENTIFIES DIFFERENT METABOLIC SIGNATURES WITHIN BOTH TUMOR-INITIATING CELLS AND STEM CELLS IN A MURINE GLIOBLASTOMA MODEL

Similar Documents

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model

P53THE METABOLIC AUTOPHAGY PATHWAY REGULATES THE RESPONSE TO TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME-INITIATING STEM CELLS

SC-15ISOLATING GLIOBLASTOMA TUMOR INITIATING PROGENITOR CELLS FROM THE SUBVENTRICULAR ZONE USING A NOVEL MINIMALLY INVASIVE APPROACH

Targeting Glioma Stem Cells

COMBINED DRUG SCREENING AND PHOSPHOPROTEOMICS IDENTIFIES CANDIDATE BRAIN TUMOR THERAPEUTICS AND NOVEL TARGETS IN PRIMARY HUMAN BRAIN TUMOR-INITIATING CELLS

Na+/K+-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

CB-15NKCC1 REGULATES MIGRATION CAPACITY OF GLIOBLASTOMA TUMOR INITIATING CELLS BY MODULATING ACTIN CYTOSKELETON THROUGH SMALL RHO GTPASES

INTEGRATED ANALYSIS IDENTIFIES DIFFERENT METABOLIC SIGNATURES WITHIN BOTH TUMOR-INITIATING CELLS AND STEM CELLS IN A MURINE GLIOBLASTOMA MODEL